SPRB — Spruce Biosciences Share News
0.000.00%
Last trade - 00:00Brief: Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study
Spruce Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Spruce Biosciences, Inc. Q2 basic EPS USD -0.32
Spruce Biosciences Inc expected to post a loss of 39 cents a share - Earnings Preview
Spruce Biosciences Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Spruce Biosciences Appoints Percival Barretto-Ko To Board Of Directors
Spruce Biosciences falls on bigger-than-expected Q1 loss
Spruce Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Spruce Biosciences Reports First Quarter 2023 Financial Results And Provides Corporate Updates
Spruce Biosciences Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Spruce Biosciences Says Has Banking Relationship With SVB, Did Not Face Any Financial Losses
Brief: Spruce Biosciences Files For Resale Of Up To 29.6 Mln Shares
Spruce Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Spruce Biosciences Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Spruce Biosciences Announces $53.6 Million Private Placement Financing
Brief: Spruce Biosciences Provides Clinical Program Updates And Outlines Anticipated Milestones For 2023
Spruce Biosciences jumps on licensing agreement with Japan's Kaken Pharma
Spruce Bio surges on licensing deal with Japan's Kaken Pharma
Brief: Spruce Biosciences And Kaken Pharmaceutical Announce Strategic Partnership And Exclusive Licensing Agreement To Develop And Commercialize Tildacerfont For Cah In Japan